Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2024 | 08-2023 | 08-2022 | 08-2021 | 08-2020 | |
| Sales | 13,294 | 12,572 | 11,738 | 9,305 | 7,861 |
| Cost of Goods | 7,552 | 7,619 | 6,939 | 5,482 | 4,802 |
| Gross Profit | 5,743 | 4,953 | 4,799 | 3,823 | 3,058 |
| Operating Expenses | 16,371 | 14,125 | 30,765 | 8,679 | 8,123 |
| Operating Income | -10,076 | -8,553 | -25,027 | -4,374 | -4,263 |
| Interest Expense | 652 | 361 | 1,594 | 165 | 157 |
| Other Income | -5,400 | -4,356 | -6,447 | 68 | -505 |
| Pre-tax Income | -16,129 | -13,269 | -33,068 | -4,471 | -4,924 |
| Income Tax | 0 | 0 | -22 | 0 | N/A |
| Net Income Continuous | -16,129 | -13,269 | -33,045 | -4,471 | -4,924 |
| Minority Interests | 38 | -55 | -196 | -9 | -9 |
| Net Income | $-16,167 | $-13,215 | $-32,849 | $-4,462 | $-4,915 |
| EPS Basic Total Ops | -0.89 | -1.30 | -11.28 | -1.80 | -2.10 |
| EPS Basic Continuous Ops | -0.89 | -1.31 | -11.34 | -1.80 | -2.14 |
| EPS Diluted Total Ops | -0.89 | -1.30 | -11.28 | -1.80 | -2.10 |
| EPS Diluted Continuous Ops | -0.89 | -1.31 | -11.34 | -1.80 | -2.14 |
| EPS Diluted Before Non-Recurring Items | -0.89 | -0.83 | -10.00 | -1.80 | N/A |
| EBITDA(a) | $-1,240 | $-1,493 | $-16,034 | $-2,649 | $-2,818 |